ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company committed to developing, manufacturing, and commercializing innovative and high-quality therapeutics. They are transforming into a leading Rare Disease company, with a focus on ophthalmology, rheumatology, nephrology, neurology, and pulmonology, alongside a strong Generics business leveraging R&D expertise and U.S.-based manufacturing.